MedAI Verdict
All comparisons

DoseMeRx vs Epocrates

Epocrates is part of the athenahealth family per its about page and costs $24.99 per month or $179.99 per year, currency not stated, with a group plan for teams and residents and access through a student email. The vendor says it has served more than a million users since 1998. Undated user reviews on GetApp and Software Advice complain about subscription cost, sponsor ads at app open and paywalled features. A hospital pharmacy running Bayesian dosing and an individual clinician after a phone reference make different purchases. DoseMeRx is reached through a demo request, Epocrates through paid epocrates+ plans.

DoseMeRx sells Bayesian forecasting for high-risk drugs to hospital pharmacists. Its homepage testimonials, picked by the vendor, include an infectious diseases specialist reporting a 70% drop in kidney injury. The evidence page lists nine papers and an IDWeek 2019 poster, with outcome claims in the vendor's own summaries.

Drug info · Reviewed November 2, 2026

DoseMeRx logo

DoseMeRx

by DoseMe

Bayesian model-informed dosing platform for high-risk medications such as vancomycin and aminoglycosides, used by hospital pharmacists.

Epocrates logo

Epocrates

by Epocrates (athenahealth) · founded 1998

Drug reference app with interaction checks, calculators, disease guidance and a beta AI Assist.

When to pick each one

DoseMeRx

  • Bayesian forecasting for high-risk medications
  • 24/7 support and staged set-up
Read the full DoseMeRx review

Epocrates

  • $24.99 per month, currency not stated
  • Drug reference, calculators, disease guidance
  • Student access via student email
Read the full Epocrates review

Score

Each row shows points earned of points available under the published rubric.

DoseMeRx

35of 100

Competitive

Epocrates

74of 100

Top-ranked
Score by dimension for DoseMeRx and Epocrates
DimensionDoseMeRxEpocratesDifference
EHR integrations (count)0 / 4.20 / 4.20
Top-3 EHR coverage (Epic / Oracle / Athena)0 / 2.40 / 2.40
Peer-reviewed papers14.7 / 2114.7 / 210
RCT / meta-analysis / systematic review0 / 63 / 6-3
Funding & adoption signal3.9 / 15.615.6 / 15.6-11.7
Pricing transparency3 / 66 / 6-3
Years in market0 / 66 / 6-6

Scroll horizontally to see every column.

How scores are computed

Pricing

DoseMeRx

TierMonthlyAnnualNotes
Enterprisen/an/aNo public price. Only a demo request form is linked.

Epocrates

TierMonthlyAnnualNotes
epocrates+, monthly$24.99n/aCancel anytime.
epocrates+, yearlyn/a$179.99The page says Save 40% when subscribing annually. Trial and refund terms are not stated.

Compliance and integrations

Documented from each vendor’s own pages.

SpecDoseMeRxEpocrates
Free tierNo / unverifiedNo / unverified
HIPAANo / unverifiedNo / unverified
SOC 2 Type IINo / unverifiedNo / unverified
EHR integrationsNot specifiedNot specified
Foundedn/a1998
HQUSUS

Scroll horizontally to see both columns.

Common questions

Open the full drug info comparison

Drug references (Lexidrug, Micromedex, Epocrates) and interaction checkers (Drugs.com, Medscape). Built for the clinician at the point of care.